Ron-Bigger Shulamit
Chief Operating Officer
Ron-Bigger Shulamit has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jul 10, 2026.
On the most recent filing, Ron-Bigger Shulamit is listed as Chief Operating Officer at Aktis Oncology, Inc. Inside the rolling window, Ron-Bigger Shulamit reported no open-market purchases and 1 open-market sale totaling $1.4M in AKTS.
Companies traded
Other insiders at AKTS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Ron-Bigger Shulamit made?
Ron-Bigger Shulamit has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company since 2026.
Which companies does Ron-Bigger Shulamit trade?
Ron-Bigger Shulamit has filed SEC Form 4 disclosures for 1 company, including AKTS.
When was Ron-Bigger Shulamit's most recent SEC Form 4 filing?
Ron-Bigger Shulamit's most recent SEC Form 4 filing on Tracefour is dated Jul 10, 2026.
What is Ron-Bigger Shulamit's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Ron-Bigger Shulamit is listed as Chief Operating Officer.
What is Ron-Bigger Shulamit's total buy and sell value in the current window?
Inside the rolling retention window, Ron-Bigger Shulamit bought $0 and sold $1.4M based on SEC Form 4 filings.
What was Ron-Bigger Shulamit's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 50,000 AKTS shares on 2026-07-08, worth $1.4M, per SEC Form 4 filings.